SMAD3 and pulmonary arterial hypertension: These findings are in good agreement with recent reports showing marked down-regulation of Smad3 in PAVSMC from human PAH lungs and in several models of experimental PH, which appeared to be responsible for both, increased cell proliferation and reduced apoptosis [32,49].